Servier
Budget
€200 — €0
EP Access
1
accredited persons
Staff
3
0.75 FTE
EU Grants
None
Mission & Goals
Founded to serve health, Servier is a global pharmaceutical group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. As a world leader in cardiology, Servier’s ambition is to become a renowned, focused and innovative player in oncology by targeting hard-to-treat cancers. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine. Headquartered in France, Servier relies on a strong geographical footprint in over 130 countries with 20 000 employees and achieved a revenue of €6.9 billion in 2025.
EU Legislative Interests
Strategic Autonomy of the EU, and the EU Industrial deal ; All policies relating to health and pharmaceuticals, such as the review of the European Pharmaceutical legislation; Critical Medicines Act; the Biotech Act; all measures relating to the protection of the environment and the Green Deal and measures relating to the digital framework. Policies for improving healthcare systems, around Non-Communicable Diseases and therapeutic adherence.
Communication Activities
See our website : https://servier.com/
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Servier is a member of EFPIA (European Federation of Pharmaceutical Industries and Associations), of the GIRP (the European Healthcare Distribution Association), and of France Industrie.
Commissioner Meetings
No recorded meetings with EU commissioners.